97093 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
CAVIAR POLYPEPTIDES
#2NANO-ENGINEERED THERAPEUTIC STEALTH CELLS
#3PROTEIN-BASED ADVANCED WOUND HEALING SYSTEM
#4MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE
#5NOVEL IL-15 PRODRUGS AND METHODS OF USE THEREOF
#6VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#7MEMBRANE PROTEIN TARGETING ENGINEERED DEUBIQUITINASES AND METHODS OF USE THEREOF
#8Methods and Compositions for Treating Aging-Associated Impairments with TIMP-2 Recombinant Proteins
#9Membrane-type metalloprotease inhibitory protein and pharmaceutical and pharmaceutical composition containing same, and respective uses thereof
#10IMMUNOGENIC PEPTIDE FRAGMENTS OF METALLOPROTEASE ADAMTS-7 AND USES THEREOF IN ANTI-ATHEROSCLEROSIS AND RELATED DISEASES
#11FUSED POLYPEPTIDE WITH MULTIFUNCTIONAL ACTIVITIES AND USE THEREOF
#12VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#13Nano-engineered therapeutic stealth cells
#14Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells
#15USE OF A PEPTIDE DERIVED FROM THE HUMAN PROTEIN NTIMP3 IN THE TREATMENT OF DIABETIC NEPHROPATHY
#16Modified anti-inflammatory proteins and method of use
#17IL-15 prodrugs and methods of use thereof
#18MMP-8 activation product, its determination and use
#19Methods and compositions for inhibiting cancer cell growth
#20Compositions and methods for modifying activity of extracellular MMP-2
#21VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#22Variants of tissue inhibitor or metalloprotienase type three (TIMP-3), compositions and methods
#23TIMP3 AS VEGF INHIBITOR
#24Use of metalloproteinase inhibitors against bacterial infections
#25Method for inhibiting ADAM proteases with cyclic peptides
#26MMP-8 activation product, its determination and use
#27Compositions and methods for inhibition of MMP8:MMP8-substrate interactions
#28Modified anti-inflammatory proteins and method of use
#29Cyclic peptides as ADAM protease inhibitors
#30INSECT METALLOPROTEINASE INHIBITORS
#31Methods and compositions using ADAM10 inhibitors to treat bacterial infections
#32Variants of tissue inhibitor of metalloproteinase type three (TIMP-3), compositions and methods
#33Bifunctional peptide
#34Compounds for inhibition of MMP13-substrate interactions and methods of use thereof to treat osteoarthritis and cartilage degeneration
#35MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#36POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
#37MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#38Compositions and methods for inhibition of MMP13:MMP-substrate interactions
#39Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-B precursor protein and tissue inhibitor of metalloproteinase-2
#40Treatment of Solid Tumors with Tissue Inhibitors of Metalloproteinases (TIMPS)
#41Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer and skin lesions
#42Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
#43Anti-ADAM-15 antibodies and utilization of the same
#44PROTEASE INHIBITION
#45USE OF PROTEIN HYDROLYSATES TO STABILIZE METALLOPROTEASE DETERGENT FORMULATIONS
#46Anti-angiogenic peptides
#47Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
#48Compounds
#49Inhibition of tumor growth and invasion by anti matrix metalloproteinase DNAzymes
#50Methionine aminopeptidase-2 inhibitors and methods of use thereof
#51Multifunctional protease inhibitors and their use in treatment of disease
#52Metalloproteinase inhibitory agent
#53Peptide Inhibitors of Matrix Metalloproteinase Activity
#54Novel polypeptide and process for producing the same, and collagenase inhibitor
#55TIMP3 as VEGF inhibitor
#56COMPOSITION AND METHOD TO INCREASE MAMMALIAN SPERM FUNCTION
#57Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#58Modified peptides as therapeutic agents
#59Methionine aminopeptidase-2 inhibitors and methods of use thereof
#60TNF-α converting enzyme inhibitory agents and method of using same
#61Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
#62Human skin equivalents expressing exogenous polypeptides
#63Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
#64Method for designing peptides
#65Therapeutic agents and methods of use thereof for the treatment of melanoma
#66Expression of potato proteinase inhibitor II in microbial hosts
#67Antiangiogenic peptides
#68Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#69Inhibition of tumor growth and invasion by anti-matrix metalloproteinase DNAzymes
#70Anti-aging and wound healing compounds
#71Methods for detecting metalloproteinase inhibitors
#72Metalloproteinase inhibitory agent
#73Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#74Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
#75Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
#76Methionine aminopeptidase-2 inhibitors and methods of use thereof
#77Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein
#78Novel biomarkers of aggrecanase activity